cancer-therapy

Documents about cancer-therapy

• Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapy#478501Europe PMC
• Author Correction: Biodegradable black phosphorus-based nanospheres for in vivo photothermal cancer therapy#20387DOAJ
• PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators.#25627NCBI PubMed Central
• A Study to Evaluate D-1553 in Combination Therapy in Non-Small Cell Lung Cancer#125859ClinicalTrials.gov
• Single-cell RNA sequencing reveals pancreatic cancer microenvironment heterogeneity for precision therapy.#135801NCBI PubMed Central
• Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia#146255ClinicalTrials.gov
• Anything that helps: cancer patient and carer perspectives on psychedelic-assisted therapy.#156744NCBI PubMed Central
• Customized Marketing Strategies for Cancer Immunocyte Therapy Based on its Distinctive Attributes.#172123NCBI PubMed Central
• Adherence to endocrine therapy and survival outcomes in hormone receptor–positive breast cancer.#193638NCBI PubMed Central
• Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma#208285ClinicalTrials.gov
• PROTACs and Glues: Striking Perspectives for Engineering Cancer Therapy À La Carte#208742HAL (France)
• DKC1 promotes colorectal cancer progression and therapy resistance by dysregulating sphingolipid biosynthesis.#209419NCBI PubMed Central
• Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC)#230424ClinicalTrials.gov
• Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma#252987ClinicalTrials.gov
• Impact théranostique de l’épitranscriptome en cancérologie#262162HAL (France)
• Cardiovascular Effects of CART Cell Therapy#300244ClinicalTrials.gov
• Vaccine Therapy in Treating Patients With Metastatic Solid Tumors#321565ClinicalTrials.gov
• Biomimetic LHRH-targeted nanogels for spatiotemporal-enhanced chemo-dynamic therapy of cancer.#340707NCBI PubMed Central
• Identifying Cell State Vulnerabilities in Pancreatic Cancer#347595Harvard DASH
• Advances in porphyrin-based photosensitizers for photodynamic therapy of A549 lung cancer.#371554NCBI PubMed Central
• Editorial: Molecular pathways and signaling molecules in cancer therapy: advances and innovations.#412247NCBI PubMed Central
• CAR T Cell Therapy in Lung Cancer: Overcoming Tumor Microenvironment-Mediated Barriers.#653447NCBI PubMed Central
• Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy#226277ClinicalTrials.gov
• Bright Light Therapy in Patients With Melanoma or Non-small Cell Lung Cancer (NSCLC) Who Are Receiving First-Line Immune Checkpoint Blockade#346913ClinicalTrials.gov
• Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer#28400ClinicalTrials.gov
• Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection#123493ClinicalTrials.gov
• Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy#67866ClinicalTrials.gov
• Photodynamic Therapy to Amplify the Response to Immunotherapy in Patients With Non-small Cell Lung Cancer With Pleural Disease#121355ClinicalTrials.gov
• A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer#172294ClinicalTrials.gov
• A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer#181734ClinicalTrials.gov
• TGF-β Receptor Inhibitor SB431542 Enhanced the Sensitivity of Gastric Cancer to 5-Fluorouracil: New Combined Targeted Therapy#274720IRIS
• Tetra-modality Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: TURBT+ Chemo/Immunotherapy+ Radiation Therapy+ Maintenance Immunotherapy vs. W&W#481749ClinicalTrials.gov
• Effects of CBT-Based Intervention Among Patients With Liver Cancer#800539ClinicalTrials.gov
• Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer#800663ClinicalTrials.gov
• Anoikis Resistance and Metastasis of Ovarian Cancer Can Be Overcome by CDK8/19 Mediator Kinase Inhibition#331562Scholar Commons
• Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer#356532ClinicalTrials.gov
• Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing Cystectomy#435776ClinicalTrials.gov
• Incidence, management, and outcome of lung cancer in patients with long‐term oxygen therapy#26252HAL (France)
• GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma#67857ClinicalTrials.gov
• Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma#127571ClinicalTrials.gov
• Immune Profile and Prognosis of Malignant Liver Tumors With Radiofrequency Ablation (RFA) Therapy#141009ClinicalTrials.gov
• Adoptive Cell Therapy for B-Cell Cancers in Patients After Stem Cell Transplantation#146441ClinicalTrials.gov
• Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors#184859ClinicalTrials.gov
• Stromal Cell–Derived Factor 1α Mediates Resistance to mTOR-Directed Therapy in Pancreatic Cancer#187185Zenodo (CERN)
• Nanotechnology in Cancer Therapy: How Nanoparticles Are Shaping the Future of Personalized Treatment.#199141NCBI PubMed Central
• Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy#226254ClinicalTrials.gov
• Marine Bioactive Peptides for Colorectal Cancer Therapy: Mechanisms, Therapeutic Potential, and Translational Challenges.#232328NCBI PubMed Central
• The Impact of DRG Payments on Nutritional Therapy Costs for Gastric Cancer Surgery Patients.#232568NCBI PubMed Central
• Decoding the microbiome: artificial intelligence-targeted gut microenvironment breakthroughs in personalized cancer therapy.#251061NCBI PubMed Central
• SPARC: A mechanism-aware spatial representation from routine histology predicts cancer survival and therapy response#259239bioRxiv / medRxiv